Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
State lawmakers pass bill to study psychedelic-assisted therapy, joining growing national movement to explore alternative treatments for substance use disorders and mental health conditions.
Federal scientists approve phase I study of mitragynine, opening new frontiers in opioid addiction research amid ongoing debates over kratom's safety and efficacy.
New research on 600,000+ veterans reveals GLP-1 drugs like Ozempic and Wegovy significantly reduce substance use disorders across alcohol, opioids, cocaine, and nicotine.
Landmark UC San Diego study reveals first decline in all four waves of overdose epidemic, driven by falling fentanyl deaths, while stimulant-related fatalities continue rising.
In a major policy shift, the FDA now advises that buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other CNS depressants.
The Department of Veterans Affairs begins enrolling 80 veterans in a groundbreaking study combining MDMA with psychotherapy to treat co-occurring PTSD and alcohol use disorder.
While U.S. overdose deaths dropped 14% in 2025, Arizona, New Mexico and North Dakota saw sharp increases amid evolving drug supply threats.
University of Arkansas Medical Sciences convenes statewide summit as data reveals 60% of adolescents in substance use treatment have co-occurring mental illness.
Federal drug enforcement officials warn that illicit fentanyl increasingly mixed with veterinary sedatives and ultra-potent synthetic opioids is creating unprecedented challenges for overdose reversal.